Axsome Therapeutics, Inc
$211.97
$7.90 (+3.87%)
$201.94Day Range$214.63
Key Statistics
Market Cap
$11.10B
Shares Outstanding
52.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 19, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$202.95
Day High
$214.63
Day Low
$201.94
Volume
645.0K
VWAP
$211.34
Prev Close
$204.07
Transactions
--
Acc. Volume
--
About Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
PHARMACEUTICAL PREPARATIONSSIC 2834925 employeesONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007(212) 332-3241IPO Nov 19, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001579428
- Composite FIGI
- BBG00B6G7GL7
- Share Class FIGI
- BBG00B6G7GM6
- Ticker Root
- AXSM
- SIC Code
- 2834
About Axsome Therapeutics, Inc (AXSM) Stock
Axsome Therapeutics, Inc (AXSM) closed the 2026-09-16 session at $211.97, up 3.87% versus the previous close (+7.90). The stock opened at $202.95 and traded between $201.94 and $214.63 during that session. Session trading volume was 645K shares. The volume-weighted average price (VWAP) is $211.34.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Axsome Therapeutics, Inc has a market capitalization of $11.10 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AXSM is listed on the XNAS exchange. The company employs approximately 925 people. Axsome Therapeutics, Inc is headquartered in NEW YORK, NY. The recorded listing date is 2015-11-19.
On this page you can find market AXSM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.